Printer Friendly
The Free Library
19,585,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

BioTherapeutics Corp. Announces Acquisition.


LARKSPUR Larkspur, city, United States
Larkspur, city (1990 pop. 11,070), Marin co., W Calif., a prestigious residential suburb of San Francisco near Mt. Tamalpais; inc. 1908. The region's scenic beauty and excellent beaches attract many visitors.
, Calif.--(BUSINESS WIRE)--Nov. 6, 1996--Martin Newman, president and chief executive officer of BioTherapeutics Corp. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
 OTC Bulletin Board OTC Bulletin Board

An electronic quotation listing of the bid and asked prices of OTC stocks that do not meet the requirements to be listed on the NASDAQ stock-listing system.
: BTEX BTEX Benzene, Toluene, Ethylbenzene, and Xylenes (volatile organic compounds) ), has announced the acquisition of Marin Land and Development Trust.

Terms of the agreement state the company paid $8 million for 100% of the Trust and its assets, in a combined stock and cash transaction. The Trust has developed a large residential tract of land in Northern California Northern California, sometimes referred to as NorCal, is the northern portion of the U.S. state of California. The region contains the San Francisco Bay Area, the state capital, Sacramento; as well as the substantial natural beauty of the redwood forests, the northern  and is scheduled to build over 2,000 single family homes at the average sales price per home of $225,000.

The gross value of the project over 5 years is $450 million and will result in a retained asset of over $45 million. After completion of the second 10-year building phase, retained assets are expected to exceed $120 million.

Alexander Myers, president of Marin Land and Development Trust, has stated, "Initial construction for the project will begin within the first quarter of 1997."

CONTACT: Gerald Communications

Gerald Sterchi, 916/854-4931

email: gerald@softcom.net

http://www.geraldsnet.com
COPYRIGHT 1996 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1996, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Nov 6, 1996
Words:168
Previous Article:Domco Inc. Announces the Closing of a $37 Million Issue.
Next Article:Cuadra Associates Debuts Internet Web Site; Interactive Site Created with Company's Own STAR Web Interface to Show Power and Flexibility of...
Topics:



Related Articles
NAPRO BIOTHERAPEUTICS, INC. ADOPTS STOCKHOLDER RIGHTS PLAN.
NaPro BioTherapeutics Overturns Bristol-Myers Squibb European Paclitaxel Administration Patent.
Northwest Biotherapeutics, Inc. Appoints Chief Financial Officer and Chief General Counsel.
Northwest Biotherapeutics, Inc. to Present Study of New Approach to Enhance Its DCVax Cancer Platform.
Northwest Biotherapeutics, Inc. to Present Preclinical Data On a Dendritic Cell-based Approach for Treating Non-small Cell Lung Cancer.
Northwest Biotherapeutics, Inc. Adopts Stockholder Rights Plan.
Northwest Biotherapeutics, Inc. Appoints Chief Medical Officer.
Northwest Biotherapeutics, Inc. Announces Fourth-Quarter and Full-Year Financial Results.
Talecris Continues Global Expansion into Europe.
GTC Biotherapeutics Grants Expanded License to PharmAthene for Further Development of Protexia(R).

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles